Multiple Sclerosis, Relapsing-Remitting trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Multiple Sclerosis, Relapsing-Remitting trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
  NCT06408259 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · New Jersey: New Brunswick, Teaneck